How to Establish Personal Data Management in Pharmaceutical Company Representative Offices in Belarus (Taking into Account the 2025 Recommendations of the National Center for Personal Data Protection)

On October 1, 2025, representatives of Borovtsov & Salei took part in an event organized by the Association of International Pharmaceutical Manufacturers (AIPM), dedicated to issues of processing and protecting personal data in the pharmaceutical industry (in the context of the 2025 recommendations of the National Center for Personal Data Protection).

The meeting was moderated by Yulia Shuba, Senior Associate at Borovtsov & Salei.

A presentation was delivered by Alena Salei, Counsel at Borovtsov & Salei.

Key issues discussed during the event included:

• Why should a representative office establish a system for handling personal data? What are the risks and liabilities?

• Specifics of the status of a foreign pharmaceutical company’s representative office when processing personal data.

• Where to start: what needs to be analyzed and checked?

• Mandatory measures to ensure the protection of personal data.

• Common mistakes and how to avoid them.

Participants received practical recommendations on mitigating the risks of violating legislation and reviewed concrete case studies from practice.

______________________________________

Borovtsov & Salei has extensive experience in commercial practice and in supporting projects related to the processing and protection of personal data.

We are ready to help pharmaceutical companies and their representative offices build an effective and secure personal data management system in compliance with the legislation of the Republic of Belarus.